Login
$MANE
$128.05 +$0.00 (0.0%) After hours

$MANE SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13D/A
13 Nov 2026 Form 4: Enright Patrick G, Director

Sold 500,000 shares ($75.2M)

13 Nov 2026 Form 4: Longitude Capital Partners V, Llc, 10% owner and 1 other

Sold 500,000 shares ($75.2M)

12 Nov 2026 144
10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

Positive topline results from Phase 3 Study ‘304’ and positive 12-month data from Phase 2/3 Study ‘302’ position VDPHL01 to potentially become the first oral treatment to receive FDA approval for pattern hair loss in nearly 30 years

09 Nov 2026 8-K: Regulation FD Disclosure; Other Events

Study ‘302’ Part B Phase 3 Topline Data in Males with Mild-to-Moderate Pattern Hair Loss November 2026 NOVEMBER 2026

19 Oct 2026 8-K: Regulation FD Disclosure; Other Events

VDPHL01, a novel orally-administered extended-release minoxidil formulation, met all primary and secondary endpoints with high statistical significance in both active treatment arms evaluating once-daily (QD) and twice-daily (BID) admini...

13 Oct 2026 SCHEDULE 13G
03 Sep 2026 Form 4: Hollander David, Chief R&D Officer

Received 9,650 shares as a grant or award · Granted 19,300 Stock Option (Right to Buy)

21 Aug 2026 SCHEDULE 13D/A
21 Aug 2026 Form 4: Montanova CAPITAL, Llc, Director and 3 others

Sold 750,000 shares ($80.4M) · Received 300,000 shares by exercise

20 Aug 2026 Form 3: Hollander David, Chief R&D Officer

No securities owned

19 Aug 2026 144
19 Aug 2026 144
18 Aug 2026 Form 4: Durso Timothy August, Chief Technical Officer

Received 3,452 shares by exercise or conversion ($42.1K) · Sold 43,500 shares ($4.69M)

18 Aug 2026 Form 4: Waldman Reid Alexander, Director

Received 3,452 shares by exercise or conversion ($42.1K) · Sold 67,500 shares ($7.28M)

17 Aug 2026 144
17 Aug 2026 144
14 Aug 2026 EFFECT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support